|
|
|
 |
|
|
Labeeb Abboud, J.D.
Senior Vice President and General Counsel, International AIDS Vaccine Initiative |
|
Margaret Anderson
Executive Director, FasterCures/The Center for Accelerating Medical Solutions |
|
|
Ramsey Baghdadi
Managing Editor, The RPM Report |
|
Rashmi Barbhaiya, Ph.D.
Chief Executive Officer and Managing Director, Advinus Therapeutics |
|
Anna Barker, Ph.D.
Director, Transformative Healthcare Networks, Co-Director, Complex Adaptive Systems Initiative and Professor, School of Life Sciences, Arizona State University |
|
Eileen Bartholomew
Senior Director, Life Sciences, X PRIZE Foundation
|
|
Robert J. Beall, Ph.D.
President and CEO, Cystic Fibrosis Foundation |
|
Michael Beckloff
President, Beckloff Associates, Inc. |
|
Gordon R. Bernard, M.D.
Professor of Medicine, Associate Vice Chancellor for Research, and Senior Associate Dean for Clinical Science, Vanderbilt University |
|
Leon Black
Co-Founder, Melanoma Research Alliance, Board Member, FasterCures, CEO, Apollo Management LP |
|
Enriqueta (Queta) Bond , Ph.D.
Partner, QE Philanthropic Advisors |
|
Jeffrey Brewer
President and CEO, Juvenile Diabetes Research Foundation |
|
Timothy N. Bullock, Ph.D.
Associate Professor, Department of Pathology Human Immune Therapy Center, University of Virginia |
|
Brook Byers
Partner, Kleiner Perkins Caufield & Byers |
|
Maureen Byrnes
Former Executive Director of the National Commission on AIDS |
|
|
Michael Cembalest
Global Head of Investment Strategy, J.P. Morgan |
|
Timothy Coetzee, Ph.D.
Chief Research Officer, National Multiple Sclerosis Society |
|
Ron Cohen, M.D.
President and Chief Executive Officer, Acorda Therapeutics, Inc |
|
N. Anthony Coles, M.D., MPH
President, Chief Executive Officer and Member of the Board, Onyx Pharmaceuticals |
|
Anthony Coyle, Ph.D.
Vice President and CSO, Centers for Therapeutic Innovation, Pfizer, Inc. |
|
Jason Cummins
Chief U.S. Economist and Head of Research, Brevan Howard Inc |
|
|
Louis DeGennaro, Ph. D.
Chief Mission Officer, Leukemia & Lymphoma Society |
|
Susan Desmond-Hellmann, M.D., MPH
Chancellor, University of California, San Francisco |
|
Ross C. DeVol
Chief Research Officer, Milken Institute |
|
Susan Wolf Ditkoff
Partner, The Bridgespan Group |
|
|
Aled M. Edwards, Ph.D.
Chief Executive, Structural Genomics Consortium |
|
|
Howard Fillit, M.D.
Executive Director, Alzheimer's Drug Discovery Foundation |
|
Garret FitzGerald, M.D., M.Sc.
Robert L. McNeil, Jr., Professor in Translational Medicine and Therapeutics, University of Pennsylvania |
|
Valentina Fossati, Ph.D.
New York Stem Cell Foundation - Helmsley Investigator, The New York Stem Cell Foundation Laboratory |
|
Stephen Friend, M.D., Ph.D.
President, Sage Bionetworks |
|
|
Brent Gendleman
President and Chief Executive Officer, 5AM Solutions
|
|
Kathy Giusti, MBA
Founder and Chief Executive Officer, Multiple Myeloma Research Foundation
|
|
George Golumbeski, Ph.D.
Senior Vice President of Business Development, Celgene Corporation
|
|
James C. Greenwood
President and CEO, Biotechnology Industry Organization (BIO) |
|
|
Margaret A. Hamburg, M.D.
Commissioner, U.S. Food and Drug Administration
|
|
Paula Hammond, Ph.D.
Bayer Chair Professor of Chemical Engineering, Massachusetts Institute of Technology |
|
Brian Harvey, M.D., Ph.D.
Vice President, U.S. Regulatory Policy, Sanofi |
|
Katie Hood, M.B.A.
Senior Fellow and Visiting Lecturer, Hart Leadership Program at Duke University's Sanford School of Public Policy |
|
Kathy Hudson, Ph.D.
Deputy Director for Science, Outreach, and Policy, National Institutes of Health |
|
Hoyoung Huh , M.D., Ph.D.
Chairman of the Board, Geron Corporation |
|
|
Thomas R. Insel, M.D.
Director, National Institute of Mental Health (NIMH), National Institutes of Health |
|
|
Kris Joshi , Ph.D.
Global Vice President - Healthcare, Oracle |
|
|
Thomas Kalil
Deputy Director for Policy, White House Office of Science and Technology Policy |
|
Regis B. Kelly, Ph.D.
Director, The California Institute for Quantitative Biosciences (QB3), University of California
|
|
Annette Kleiser
Senior Program Officer, Industry Alliances, University of Southern California Stevens Institute |
|
Annette Kleiser, Ph.D.
Senior Program Officer, Industry Initiatives, USC Stevens Institute for Innovation, University of Southern California |
|
Fernando Kreutz, M.D., Ph.D.
Founder and President, FK-Biotec |
|
|
Warren B. Lammert
Chairman and Co-Founder, The Epilepsy Therapy Project |
|
Peter Lansbury, Jr., Ph.D.
Chief Scientific Officer, LINK Medicine and Professor of Neurology, Harvard Medical School |
|
Debra R. Lappin
President, Council for American Medical Innovation; Senior Vice President, B&D Consulting |
|
Daniel Laster, J.D.
General Counsel, Legal Affairs, PATH |
|
Jonathan Leff
Managing Director, Healthcare, Warburg Pincus |
|
Susan Love, M.D.
President and Medical Director, Dr. Susan Love Research Foundation |
|
|
Michael Manganiello
Partner, HCM Strategists |
|
David M. Margulies, M.D.
Senior Associate in Medicine and Director of The Gene Partnership (TGP), Children's Hospital Boston |
|
James McCullough, MBA
Chief Executive Officer, Exosome Diagnostics, Inc.
|
|
Gerald McDougall
Principal, Personalized Medicine and Health Sciences Practices,PricewaterhouseCoopers |
|
Teri Melese, Ph.D.
Associate Professor of Medicine and Director of Research Technologies and Alliances, School of Medicine, Dean's Office, University of California, San Francisco |
|
Gwen A. Melincoff
Senior Vice President, Business Development, Strategic Investment Group, Shire Pharmaceuticals
|
|
John Mendlein, Ph.D., J.D.
Executive Chairman, Fate Therapeutics and Chairman, aTyr Pharma |
|
Michael Milken
Chairman, Milken Institute and Chairman, FasterCures |
|
Lesa Mitchell
Vice President, Ewing Marion Kauffman Foundation |
|
Chris Morrison
Editor-in-Chief, Biopharmaceuticals and Consumer Products at Elsevier Business Intelligence
|
|
|
Larry A. Nagahara, Ph.D.
Acting Director, Office of Physical Sciences-Oncology, National Cancer Institute
|
|
Garry Neil, M.D.
Corporate Vice President, Corporate Office of Science and Technology, Johnson & Johnson |
|
Sean Nolan
Chief Architect and General Manager, Health Solutions Group, Microsoft Corp.
|
|
|
Dennis G. Podlesak, M.B.A.
Partner, Domain Associates |
|
George Poste, Ph.D., D.V.M
Chief Scientist, Complex Adaptive Systems Initiative, Arizona State University |
|
|
Raul Rabadan, Ph.D.
Assistant Professor, Department of Biomedical Informatics, Center for Computational Biology and Bioinformatics, Columbia University College of Physicians and Surgeons |
|
Michael Rawlins
Chairman, National Institute of Health and Clinical Excellence |
|
Susan Rohrer, Ph.D.
Senior Director, External Scientific Affairs, Worldwide Licensing, Merck Research Laboratories |
|
|
Ken Schaner, J.D.
Managing Partner, Schaner & Lubitz
|
|
Wendy Selig, M.S.
President and CEO, Melanoma Research Alliance |
|
Sebastian Seung, Ph.D.
Professor of Computational Neuroscience, MIT; author of Connectome: How the Brain's Wiring Makes Us Who We Are |
|
Padmanee Sharma, M.D., Ph.D.
Associate Professor, Department of Genitourinary Medical Oncology, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center |
|
Todd Sherer, Ph.D.
Chief Executive Officer, Michael J. Fox Foundation for Parkinson's Research |
|
Jeffrey Shuren, M.D., J.D.
Director, Center for Devices and Radiological Health, U.S. Food and Drug Administration
|
|
Ellen V. Sigal, Ph.D.
Chair and Founder, Friends of Cancer Research |
|
Greg Simon, J.D.
Senior Vice President, Patient Engagement, Pfizer Inc. |
|
Josh Sommer
Executive Director, Chordoma Foundation |
|
Stephen P. Spielberg, MD, PhD
Deputy Commissioner for Medical Products and Tobacco, U.S. Food and Drug Administration |
|
David Steinberg
Partner, PureTech Ventures |
|
Melissa Stevens
Director of Strategic Initiatives, FasterCures |
|
Brent Stockwell, Ph.D.
Associate Professor, Biological Science, Columbia University |
|
|
Jeffrey M. Trent, Ph.D., FACMG
President and Research Director, Van Andel Research Institute; President and Research Director, The Translational Genomics Research Institute (TGen) |
|
Reed Tuckson, M.D.
Executive Vice President and Chief of Medical Affairs, UnitedHealth Group |
|
|
Steve Usdin
Senior Editor (Washington), BioCentury |
|
|
Chris Varma, Ph.D.
Entrepreneur-in-Residence, Third Rock Ventures |
|
George Vradenburg, J.D.
Chairman, USAgainstAlzheimer's |
|
|
Scott J. Weir, Pharm.D., Ph.D.
Director, Institute for Advancing Medical Innovation, University of Kansas Cancer Center |
|
Timothy M. Wright, M.D.
Global Head of Translational Sciences, Novartis Institutes for BioMedical Research (NIBR) |
